WeVote
Log In

Bill

Bill

HB 3350

PATIENT ACCESS 340B PHARMACY

104th Regular Session Introduced by Carol Ammons and 22 co-sponsors

HB 3350 aims to expand patient access to discounted 340B program medications in Illinois, affecting affordability for uninsured and underinsured populations at safety-net facilities.

Added Co-Sponsor Rep. Elizabeth "Lisa" Hernandez
0
WeVote Research Nonpartisan
Bill Summary · HB 3350

Legislative bill overview

HB 3350 addresses patient access to medications through the 340B drug pricing program, which allows certain healthcare entities (hospitals, clinics, Medicare/Medicaid providers) to purchase drugs at discounted rates. The bill appears designed to expand or clarify patient access to these discounted medications, though specific language would determine whether it increases transparency, requires pass-through of savings, or modifies program participation rules.

Why is this important

The 340B program affects medication affordability for vulnerable populations served by safety-net hospitals and clinics. How discounts are distributed between institutional profits and patient access directly impacts out-of-pocket costs for uninsured and underinsured Illinoisans, making this a significant healthcare equity issue.

Potential points of contention

  • Industry opposition: Pharmacy benefit managers and some hospitals may resist requirements to pass savings to patients, arguing it reduces institutional resources for uncompensated care
  • Program integrity concerns: Debate over whether expanded access requirements could lead to program abuse or diversion of discounted drugs outside intended safety-net populations
  • Implementation costs: Healthcare providers may argue compliance requirements impose administrative burdens that increase operational expenses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.